These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27685259)

  • 1. Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
    Solassol J; Vendrell J; Märkl B; Haas C; Bellosillo B; Montagut C; Smith M; O'Sullivan B; D'Haene N; Le Mercier M; Grauslund M; Melchior LC; Burt E; Cotter F; Stieber D; Schmitt FL; Motta V; Lauricella C; Colling R; Soilleux E; Fassan M; Mescoli C; Collin C; Pagès JC; Sillekens P
    PLoS One; 2016; 11(9):e0163444. PubMed ID: 27685259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.
    Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomić S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X
    Virchows Arch; 2021 May; 478(5):851-863. PubMed ID: 33170334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples.
    Offerman S; Prinsen CF; Knol A; Methorst N; Kamphorst J; Niemantsverdriet M
    Diagn Pathol; 2021 Aug; 16(1):70. PubMed ID: 34344387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
    Weyn C; Van Raemdonck S; Dendooven R; Maes V; Zwaenepoel K; Lambin S; Pauwels P
    BMC Cancer; 2017 Feb; 17(1):139. PubMed ID: 28201998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
    Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
    BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid
    Al-Turkmani MR; Suriawinata MA; Deharvengt SJ; Green DC; Black CC; Shirai K; Dragnev KH; Tsongalis GJ
    Pract Lab Med; 2020 May; 20():e00156. PubMed ID: 32181314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Idylla
    Makutani Y; Sakai K; Yamada M; Wada T; Chikugo T; Satou T; Iwasa Y; Yamamoto H; de Velasco MA; Nishio K; Kawamura J
    Int J Clin Oncol; 2022 Jul; 27(7):1180-1187. PubMed ID: 35474548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
    Melchior L; Grauslund M; Bellosillo B; Montagut C; Torres E; Moragón E; Micalessi I; Frans J; Noten V; Bourgain C; Vriesema R; van der Geize R; Cokelaere K; Vercooren N; Crul K; Rüdiger T; Buchmüller D; Reijans M; Jans C
    Exp Mol Pathol; 2015 Dec; 99(3):485-91. PubMed ID: 26407762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Somatic Mutation Testing in Colorectal Cancer by Use of a Fully Automated System and Single-Use Cartridge: A Comparison with Next-Generation Sequencing.
    Al-Turkmani MR; Godwin KN; Peterson JD; Tsongalis GJ
    J Appl Lab Med; 2018 Sep; 3(2):178-184. PubMed ID: 33636938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and performance of the Idylla™ NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspiration.
    Hamadou M; Lopez J; Benzerdjeb N; Cugnet-Anceau C; Schnoering G; Besançon J; Mezrag S; Lapras V; Denier ML; Descotes F; Decaussin-Petrucci M
    Diagn Cytopathol; 2021 Dec; 49(12):1265-1271. PubMed ID: 34698448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
    Behnke A; Cayre A; De Maglio G; Giannini G; Habran L; Tarsitano M; Chetta M; Cappellen D; Lespagnol A; Le Naoures C; Massazza G; Destro A; Bonzheim I; Rau A; Battmann A; Kah B; Watkin E; Hummel M
    Pathol Oncol Res; 2023; 29():1610707. PubMed ID: 36798672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
    Colling R; Bancroft H; Langman G; Soilleux E
    Virchows Arch; 2019 Feb; 474(2):187-192. PubMed ID: 30470932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-rapid Idylla™
    Qiu T; Zhang F; Zheng B; Feng Z; Li W; Zeng H; Chu L; Ying J
    Front Oncol; 2023; 13():1064487. PubMed ID: 37064089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer.
    Prieto-Potin I; Montagut C; Bellosillo B; Evans M; Smith M; Melchior L; Reiltin W; Bennett M; Pennati V; Castiglione F; Bürrig KF; Cooper U; Dockhorn-Dworniczak B; Rossenbach C; Luna-Aguirre CM; Barrera-Saldaña HA; Machado JC; Costa JL; Yacobi R; Tabibian-Keissar H; Buglioni S; Ronchetti L; Douglas-Berger L; Dubbink HJ; Alorini M; Sabourin JC; Rojo F
    J Mol Diagn; 2018 Sep; 20(5):664-676. PubMed ID: 29959022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Biocartis Idylla™ cartridge-based assay for detection of microsatellite instability in colorectal cancer tissues.
    Mindiola-RomeroMD AE; GreenBS DC; Al-TurkmaniPhD MR; GodwinBS KN; MackayBS AC; TafeMD LJ; RenMD B; TsongalisPhD GJ
    Exp Mol Pathol; 2020 Oct; 116():104519. PubMed ID: 32822722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.
    Yoshino T; Muro K; Yamaguchi K; Nishina T; Denda T; Kudo T; Okamoto W; Taniguchi H; Akagi K; Kajiwara T; Hironaka S; Satoh T
    EBioMedicine; 2015 Apr; 2(4):317-23. PubMed ID: 26137573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of
    Ilie M; Butori C; Lassalle S; Heeke S; Piton N; Sabourin JC; Tanga V; Washetine K; Long-Mira E; Maitre P; Yazbeck N; Bordone O; Lespinet V; Leroy S; Cohen C; Mouroux J; Marquette CH; Hofman V; Hofman P
    Oncotarget; 2017 Nov; 8(61):103055-103062. PubMed ID: 29262544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed, paraffin-embedded tissue of human lung cancer.
    Xu Y; Zhang L; Jia L; Ren M; Xue T; Bai Q; Yao Q; Wei R; Zhou X; Zhu X
    J Thorac Dis; 2024 Jan; 16(1):40-50. PubMed ID: 38410581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study.
    Gatius S; Velasco A; Varela M; Cuatrecasas M; Jares P; Setaffy L; Bonhomme B; Santon A; Lindemann K; Croce S; Davidson B; Lax S; Palacios J; Matias-Guiu X
    Virchows Arch; 2022 May; 480(5):1031-1039. PubMed ID: 35124717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.